Drug:
Reaction: BLOOD GLUCOSE INCREASED
20250101 - 20251231
No. 1 - 100
No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
1 | 25491764 |
US |
57 | 2 |
Extra dose administered, Feeling abnormal, Feeling hot, Blood glucose increased, Injection site pain, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
2 | 25491942 |
US |
59 | 2 |
Device defective, Drug dose omission by device, Renal impairment, Vomiting, Nausea, Diarrhoea, Abdominal pain, Blood glucose increased, Blood glucose decreased, Urine albumin/creatinine ratio increased, |
||||
SEMAGLUTIDE, SEMAGLUTIDE, SEMAGLUTIDE, |
||||
3 | 25492235 |
CN |
2 | |
Diabetic complication, Blood glucose increased, |
||||
INSULIN GLARGINE, |
||||
4 | 25493297 |
US |
77 | 2 |
Parkinson^s disease, Blood glucose increased, Incorrect product administration duration, |
||||
INSULIN HUMAN, INSULIN HUMAN, |
||||
5 | 25493300 |
US |
2 | |
Blood glucose increased, |
||||
TIRZEPATIDE, |
||||
6 | 25493624 |
US |
||
Blood glucose increased, |
||||
RELUGOLIX, RELUGOLIX, FLUTICASONE PROPIONATE, TRIPROLIDINE HCL, ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL, GLIPIZIDE, LISINOPRIL, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
7 | 25493735 |
US |
74 | 2 |
Fungal infection, Injection site pain, Blood glucose increased, Drug ineffective, |
||||
DULAGLUTIDE, DULAGLUTIDE, DULAGLUTIDE, DULAGLUTIDE, |
||||
8 | 25493967 |
US |
2 | |
Glycosylated haemoglobin increased, Blood glucose increased, Drug ineffective, |
||||
DULAGLUTIDE, |
||||
9 | 25494372 |
US |
55 | 2 |
Blood glucose increased, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
10 | 25494376 |
US |
70 | 2 |
Blood glucose increased, Product dose omission issue, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, INSULIN ASPART, |
||||
11 | 25494396 |
US |
74 | 1 |
Renal impairment, Urine abnormality, Vomiting, SARS-CoV-2 test positive, Dizziness, Hot flush, Blood glucose increased, Constipation, |
||||
RELUGOLIX, RELUGOLIX, PREDNISONE, ABIRATERONE ACETATE, ABIRATERONE, BENZONATATE, CLOPIDOGREL BISULFATE, CYANOCOBALAMIN, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, GLIPIZIDE, IPRATROPIUM BROMIDE, FINERENONE, INSULIN GLARGINE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, MIDODRINE HYDROCHLORIDE, RANOLAZINE, RASAGILINE MESYLATE, ROSUVASTATIN CALCIUM, CARBIDOPA AND LEVODOPA, ERGOCALCIFEROL, DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE, |
||||
12 | 25494951 |
US |
80 | 1 |
Injection site erythema, Drug ineffective, Blood glucose increased, Glycosylated haemoglobin increased, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
13 | 25495512 |
AU |
1 | |
Haemoglobin decreased, Haematocrit decreased, Mean cell haemoglobin decreased, Blood glucose increased, Blood cholesterol decreased, |
||||
CLOZAPINE, |
||||
14 | 25495537 |
US |
79 | 1 |
Blood glucose increased, |
||||
INSULIN GLARGINE, INSULIN GLARGINE, INSULIN GLARGINE, INSULIN GLARGINE, INSULIN GLARGINE, INSULIN GLARGINE, |
||||
15 | 25495662 |
US |
2 | |
Blood glucose increased, Device issue, Expired product administered, |
||||
INSULIN GLARGINE, |
||||
16 | 25495944 |
US |
72 | 1 |
Blood glucose increased, |
||||
INSULIN LISPRO, |
||||
17 | 25499798 |
70 | 1 | |
Peripheral swelling, Blood glucose increased, Skin ulcer, Impaired healing, |
||||
APALUTAMIDE, |
||||
18 | 25491185 |
US |
63 | 1 |
Blood glucose increased, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
19 | 25491253 |
US |
68 | 1 |
Glycosylated haemoglobin increased, Blood glucose increased, Drug ineffective, Intercepted product storage error, |
||||
INSULIN GLARGINE, |
||||
20 | 25491439 |
US |
67 | 2 |
Drug ineffective, Blood glucose increased, |
||||
INSULIN GLARGINE, |
||||
21 | 25491441 |
US |
||
Blood glucose increased, Drug ineffective, |
||||
INSULIN GLARGINE, |
||||
22 | 25490150 |
CA |
62 | 2 |
Tardive dyskinesia, Abnormal behaviour, Lip swelling, Hypersensitivity, Dysphagia, Peripheral swelling, Psoriasis, Tremor, Mouth swelling, Dry skin, Blood glucose increased, |
||||
PALIPERIDONE PALMITATE, PALIPERIDONE PALMITATE, PALIPERIDONE PALMITATE, |
||||
23 | 25490166 |
US |
66 | 1 |
Blood glucose increased, Drug ineffective, Blood glucose decreased, Blood glucose fluctuation, |
||||
INSULIN GLARGINE, INSULIN GLARGINE, INSULIN LISPRO, |
||||
24 | 25490174 |
US |
33 | 2 |
Hepatic enzyme increased, Blood glucose increased, Hypertension, Nausea, Sleep disorder, Weight decreased, Abdominal pain upper, Illness, Feeding disorder, |
||||
ROMOSOZUMAB-AQQG, |
||||
25 | 25486370 |
US |
52 | 2 |
Blood glucose increased, |
||||
INSULIN LISPRO, INSULIN LISPRO, INSULIN LISPRO, |
||||
26 | 25486557 |
US |
78 | 1 |
Choking, Cerebrovascular accident, Clostridium difficile infection, Skin discolouration, Skin warm, Dysarthria, Dysphagia, Liver function test abnormal, Urinary tract infection, Hypersomnia, Blood glucose increased, Decreased appetite, Eye movement disorder, Miosis, Rash macular, |
||||
MOMELOTINIB, LEVETIRACETAM, OXCARBAZEPINE, ACYCLOVIR, INSULIN GLARGINE, INSULIN LISPRO, |
||||
27 | 25486619 |
CO |
19 | 2 |
Immunosuppressant drug level increased, Discouragement, Pyrexia, Back pain, Somnolence, Feeling hot, Blood glucose increased, Pallor, Weight decreased, |
||||
TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, ENALAPRIL, MYCOPHENOLIC ACID, MYCOPHENILIC ACID, |
||||
28 | 25486662 |
CA |
||
Abdominal distension, Acne, Arthritis, Asthenia, Blood glucose increased, Concussion, Crohn^s disease, Diabetic neuropathy, Ear pain, Feeling abnormal, Frequent bowel movements, Muscle rupture, Pain in extremity, Rhinorrhoea, Sciatica, Vaginal discharge, Weight fluctuation, Abdominal pain, Arthralgia, Constipation, Fatigue, Headache, Influenza, Muscle spasms, Omphalitis, Weight decreased, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, SEMAGLUTIDE, CELECOXIB, DEXLANSOPRAZOLE, FLUCONAZOLE, FOLIC ACID, EMPAGLIFLOZIN, POLYETHYLENE GLYCOL (3350), POLYETHYLENE GLYCOL 3350, POLYETHYLENE GLYCOL 400, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METHOTREXATE, METHOTREXATE SODIUM, ROSUVASTATIN, |
||||
29 | 25487096 |
GB |
69 | 2 |
Acute kidney injury, Overdose, Polyuria, Hypotension, International normalised ratio abnormal, Dialysis, Medication error, Amnesia, Abdominal pain upper, Nausea, Blindness, Abdominal discomfort, Tinnitus, Palmoplantar keratoderma, Atrial tachycardia, Dry skin, Immunisation, Tension headache, Alopecia, Diarrhoea, Angioedema, Headache, Hallucination, COVID-19, Dizziness, Arthralgia, Pain of skin, Peripheral swelling, Disturbance in attention, Cognitive disorder, Memory impairment, Visual impairment, Diplopia, Vasculitis, Carotid artery occlusion, Transient ischaemic attack, Pruritus genital, Subarachnoid haemorrhage, Sleep terror, Vomiting, Ventricular tachycardia, Pericarditis, Cardiospasm, Dyspnoea, Fatigue, Anxiety, Muscular weakness, Feeling abnormal, Insomnia, Heart rate increased, Blood glucose increased, Muscle twitching, Dehydration, Pyrexia, Hyperhidrosis, Chest pain, Back pain, Rash, Lip swelling, Pruritus, Myocardial infarction, Palpitations, Tachycardia, Pain, Anosmia, Eye pruritus, Facial pain, Migraine, Malaise, Intentional product use issue, Intentional product misuse, Incorrect product administration duration, Medication error, Off label use, |
||||
OLANZAPINE, OLANZAPINE, OLANZAPINE, ESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM CAPSULE, DELAYED RELEASE, ESOMEPRAZOLE MAGNESIUM DELAYED RELEASE CAPSULES, ARIPIPRAZOLE, ARIPIPRAZOLE, LITHIUM CARBONATE, LITHIUM CARBONATE, LITHIUM CARBONATE, LITHIUM CARBONATE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, WARFARIN, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, WARFARIN SODIUM, WARFARIN, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, APIXABAN, APIXABAN, BISOPROLOL FUMARATE, BISOPROLOL FUMARATE, BISOPROLOL FUMARATE, BISOPROLOL FUMARATE, BISOPROLOL FUMARATE, CANDESARTAN, CANDESARTAN, CANDESARTAN, CANDESARTAN, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, ISOSORBIDE MONONITRATE, ISOSORBIDE MONONITRATE, ISOSORBIDE MONONITRATE, SIMVASTATIN, SIMVASTATIN, DAPAGLIFLOZIN, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, DIGOXIN, DIGOXIN, DIGOXIN, DIGOXIN, DIGOXIN, DIGOXIN, DIGOXIN, HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE, ISOSORBIDE DINITRATE, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LINAGLIPTIN, LINAGLIPTIN, LINAGLIPTIN, LINAGLIPTIN, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CANDESARTAN CILEXETIL, FELODIPINE, FELODIPINE EXTENDED-RELEASE TABLETS, SIMVASTATIN, NAPROXEN, NAPROXEN SODIUM, AMITRIPTYLINE HYDROCHLORIDE, ESTRIOL, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, SIMVASTATIN, INSULIN GLARGINE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, BUMETANIDE, BISOPROLOL FUMARATE, BISOPROLOL FUMARATE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, |
||||
30 | 25487456 |
CN |
59 | 2 |
Myelosuppression, Pyrexia, Anger, Agitation, Apathy, Anaemia, Pallor, Breath sounds abnormal, Rales, Serum amyloid A protein increased, Blood glucose increased, Prealbumin decreased, Blood alkaline phosphatase decreased, Protein total decreased, Blood albumin decreased, Blood cholinesterase decreased, Blood urea increased, Cystatin C increased, Blood potassium decreased, Blood sodium increased, Blood chloride increased, Blood calcium decreased, Blood magnesium decreased, Blood phosphorus decreased, Interleukin level increased, Blood calcitonin increased, Activated partial thromboplastin time shortened, Blood fibrinogen decreased, Prothrombin time prolonged, Fibrin D dimer increased, Mucosal discolouration, |
||||
RITUXIMAB, POLATUZUMAB VEDOTIN, EPIRUBICIN HYDROCHLORIDE, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, |
||||
31 | 25488351 |
US |
57 | 1 |
Blood glucose increased, Balance disorder, Fall, Thinking abnormal, Paraesthesia, Burning sensation, Fatigue, Tremor, |
||||
INSULIN LISPRO, LISINOPRIL, HYDROCHLOROTHIAZIDE, EZETIMIBE, |
||||
32 | 25488357 |
US |
2 | |
Dementia, Product dose omission issue, Blood glucose increased, |
||||
INSULIN LISPRO, |
||||
33 | 25488694 |
US |
78 | 1 |
Blood glucose increased, Glycosylated haemoglobin increased, Drug ineffective, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, INSULIN HUMAN, |
||||
34 | 25489004 |
US |
47 | 1 |
Product storage error, Blood glucose increased, |
||||
INSULIN LISPRO, |
||||
35 | 25489425 |
US |
64 | 2 |
Injection site pain, Product storage error, Blood glucose increased, |
||||
INSULIN GLARGINE, PREDNISONE, |
||||
36 | 25489441 |
US |
80 | 1 |
Blood glucose increased, Surgery, Intentional dose omission, |
||||
INSULIN GLARGINE, |
||||
37 | 25490435 |
US |
45 | 1 |
Blood glucose increased, Dizziness, Vision blurred, Fall, |
||||
INSULIN LISPRO, |
||||
38 | 25490447 |
DE |
22 | 1 |
Ketoacidosis, Blood glucose increased, Glycosylated haemoglobin increased, Hypoglycaemia, |
||||
INSULIN LISPRO-AABC, INSULIN DEGLUDEC, |
||||
39 | 25481108 |
US |
68 | 2 |
Eye infection, Blood glucose increased, Product dose omission issue, Incorrect dose administered, Injection site erythema, Injection site pain, Injection site pruritus, Injection site discolouration, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
40 | 25481363 |
US |
67 | 1 |
Blood glucose increased, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
41 | 25481538 |
US |
2 | |
Inability to afford medication, Intentional product misuse, Blood glucose increased, |
||||
SEMAGLUTIDE, |
||||
42 | 25481599 |
US |
2 | |
Age-related macular degeneration, Pneumonia, Compression fracture, Benign renal neoplasm, Syncope, Illness, Limb injury, Gastrointestinal disorder, Blood glucose increased, Product storage error, |
||||
INSULIN DEGLUDEC, SEMAGLUTIDE, |
||||
43 | 25481927 |
US |
82 | 2 |
Drug ineffective, Blood glucose increased, Injection site bruising, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
44 | 25481932 |
US |
63 | 2 |
Off label use, Blood glucose increased, Drug ineffective, |
||||
INSULIN LISPRO, HUMAN INSULIN, |
||||
45 | 25482132 |
CN |
72 | 2 |
Deafness, Blood glucose increased, Wrong product administered, |
||||
HUMAN INSULIN, HUMAN INSULIN, DAPAGLIFLOZIN, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, HUMAN INSULIN, |
||||
46 | 25482149 |
US |
69 | 1 |
Hip arthroplasty, Weight increased, Blood glucose increased, Drug ineffective, |
||||
SEMAGLUTIDE, SEMAGLUTIDE, |
||||
47 | 25482156 |
US |
21 | 1 |
Unresponsive to stimuli, Liver function test abnormal, Methaemoglobinaemia, Lactic acidosis, Multiple organ dysfunction syndrome, Vomiting, Generalised tonic-clonic seizure, Sinus tachycardia, Electrocardiogram QT prolonged, Cardiac failure congestive, Pleural effusion, Pulmonary oedema, Renal failure, Blood glucose increased, Intentional overdose, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, BUPROPION, OLANZAPINE, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, |
||||
48 | 25482239 |
US |
19 | |
Blood glucose increased, |
||||
INSULIN LISPRO, |
||||
49 | 25483777 |
US |
68 | 2 |
Off label use, Product dose omission issue, Blood glucose increased, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
50 | 25483833 |
US |
72 | 1 |
Blood glucose increased, Hydrocephalus, |
||||
TIOTROPIUM BROMIDE INHALATION SPRAY, LEVOTHYROXINE, WARFARIN, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, |
||||
51 | 25483849 |
ZA |
51 | 2 |
Amnesia, Blood pressure increased, Blood glucose increased, Disorientation, Speech disorder developmental, White blood cell count decreased, |
||||
FINGOLIMOD HYDROCHLORIDE, DULOXETINE HYDROCHLORIDE, DULOXETIN HYDROCHLORIDE, DULOXETINE, |
||||
52 | 25484102 |
US |
2 | |
Blood glucose increased, |
||||
53 | 25484157 |
US |
67 | 2 |
Blood glucose increased, |
||||
DUPILUMAB, INSULIN GLARGINE, INSULIN LISPRO, GABAPENTIN, EMPAGLIFLOZIN, MAGNESIUM OXIDE, BUPROPION HYDROCHLORIDE, FERROUS FUMARATE AND POLYSACCHRIDE IRON VITAMIN MINERAL COMPLEX SUPPLEMENT, ISOSORBIDE MONONITRATE, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, ERGOCALCIFEROL, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ESCITALOPRAM, AMLODIPINE BESYLATE, TOLTERODINE TARTRATE, TOLTERODINE, FEXOFENADINE HYDROCHLORIDE, FEXOFENADINE HYDROCHLORIDE ORAL, FEXOFENADINE HCL, PANCRELIPASE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, SUCRALFATE, SUCRALFATE ORAL SUSPENSION, SUCRALFATE ORAL, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, SEMAGLUTIDE, |
||||
54 | 25484627 |
63 | 1 | |
Diarrhoea, Sleep disorder, Blood glucose increased, Blood pressure increased, |
||||
TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, |
||||
55 | 25485153 |
US |
14 | 2 |
Blood glucose increased, Headache, Nausea, Somnolence, Abdominal pain upper, |
||||
INSULIN LISPRO, |
||||
56 | 25485982 |
US |
||
Blood glucose increased, Headache, Pain, Productive cough, |
||||
NEMOLIZUMAB-ILTO, GLIMEPIRIDE, INSULIN ASPART, |
||||
57 | 25486233 |
US |
80 | 2 |
Blood glucose increased, Feeling abnormal, |
||||
INSULIN LISPRO-AABC, INSULIN DEGLUDEC, |
||||
58 | 25486298 |
US |
1 | |
Blood glucose increased, |
||||
EVOLOCUMAB, EVOLOCUMAB, |
||||
59 | 25475914 |
US |
73 | 2 |
Blood glucose increased, Muscular weakness, Confusional state, Feeding disorder, Asthenia, Nausea, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, INSULIN GLARGINE, INSULIN ASPART, |
||||
60 | 25476286 |
CA |
59 | 2 |
Blood glucose increased, Mental impairment, Migraine, Decreased appetite, Weight decreased, Drug ineffective, |
||||
SEMAGLUTIDE, CANDESARTAN, TOPIRAMATE, |
||||
61 | 25476307 |
US |
43 | 2 |
Illness, Extrasystoles, Brain fog, Malnutrition, Food aversion, Menopause, Decreased appetite, Weight decreased, Blood glucose increased, Expired product administered, Prescription drug used without a prescription, |
||||
SEMAGLUTIDE, SEMAGLUTIDE, |
||||
62 | 25476359 |
US |
2 | |
Weight decreased, Blood glucose increased, Inappropriate schedule of product administration, |
||||
INSULIN GLARGINE, INSULIN GLARGINE, |
||||
63 | 25476597 |
US |
68 | 2 |
Blood glucose increased, |
||||
INSULIN LISPRO, |
||||
64 | 25476687 |
CA |
66 | 2 |
Aortic arteriosclerosis, Blood glucose increased, Blood pressure diastolic abnormal, Blood pressure diastolic decreased, Blood pressure fluctuation, Blood pressure increased, Blood pressure systolic increased, Diabetic ketoacidosis, Intentional product use issue, Oxygen saturation decreased, Type 2 diabetes mellitus, Weight increased, Weight decreased, |
||||
RITUXIMAB, SEMAGLUTIDE, SEMAGLUTIDE, EMPAGLIFLOZIN, PREDNISONE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, DIPHENHYDRAMINE HYDROCHLORIDE, CALCIUM, DIPHENHYDRAMINE HYDROCHLORIDE, FOLIC ACID, INSULIN LISPRO, INSULIN DETEMIR, METHOTREXATE, METHOTREXATE SODIUM, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, NADOLOL, PAROXETINE HYDROCHLORIDE HEMIHYDRATE, PAROXETINE, PAROXETINE HYDROCHLORIDE, RAMIPRIL, RISEDRONATE SODIUM, RISEDRONATE SODIUM, ROSUVASTATIN, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ERGOCALCIFEROL, |
||||
65 | 25476724 |
US |
72 | 2 |
Abdominal distension, Dizziness, Blood glucose increased, Blood glucose decreased, |
||||
INSULIN LISPRO, |
||||
66 | 25476736 |
US |
61 | |
Blood glucose increased, Product dose omission issue, |
||||
INSULIN LISPRO, INSULIN LISPRO, INSULIN LISPRO, |
||||
67 | 25476989 |
US |
73 | 1 |
Blood glucose increased, |
||||
INSULIN LISPRO, |
||||
68 | 25477368 |
US |
59 | |
Vitreous degeneration, Macular oedema, Inappropriate schedule of product administration, Asthma, Nasal congestion, Sinusitis, Wheezing, Blood glucose increased, Gastrooesophageal reflux disease, Dyspnoea, Cough, Chest pain, Presyncope, Myalgia, Weight increased, Bronchitis, Dysphonia, Dizziness, Eye pain, Fibromyalgia, Arthralgia, Gait disturbance, Insurance issue, Fatigue, Taste disorder, Muscle spasms, Paraesthesia, Asthenia, Parosmia, Rhinitis, Pain, Rhinorrhoea, Abdominal pain, Diarrhoea, Nausea, Nasal polyps, |
||||
BENRALIZUMAB, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, OMEPRAZOLE MAGNESIUM, EPINEPHRINE, EZETIMIBE, LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE, MONTELUKAST SODIUM, ZOLPIDEM TARTRATE, PREDNISONE, CETIRIZINE HYDROCHLORIDE, |
||||
69 | 25477405 |
CA |
2 | |
Hypertensive crisis, Blood cholesterol abnormal, Blood glucose increased, |
||||
VEDOLIZUMAB, VEDOLIZUMAB, TIOTROPIUM BROMIDE, FLUTICASONE PROPIONATE, |
||||
70 | 25477531 |
US |
58 | 2 |
Product storage error, Blood glucose increased, |
||||
INSULIN LISPRO, |
||||
71 | 25477905 |
US |
74 | 1 |
Hypoacusis, Memory impairment, Blood glucose increased, Accidental underdose, |
||||
INSULIN LISPRO, INSULIN GLARGINE AND LIXISENATIDE, INSULIN GLARGINE, |
||||
72 | 25478360 |
US |
69 | 2 |
Hypersensitivity, Infusion site pain, Infusion site haemorrhage, Blood glucose increased, Therapeutic product effect incomplete, |
||||
INSULIN LISPRO, INSULIN LISPRO-AABC, INSULIN ASPART, |
||||
73 | 25478703 |
US |
55 | 1 |
Blood glucose increased, Tremor, Blood glucose decreased, Hyperhidrosis, |
||||
INSULIN LISPRO, |
||||
74 | 25478706 |
US |
80 | 2 |
Incorrect dose administered, Blood glucose increased, |
||||
INSULIN LISPRO, DULAGLUTIDE, DULAGLUTIDE, INSULIN DEGLUDEC, |
||||
75 | 25478707 |
US |
56 | 2 |
Headache, Glycosylated haemoglobin increased, Blood glucose increased, Drug ineffective, |
||||
TIRZEPATIDE, TIRZEPATIDE, INSULIN LISPRO, |
||||
76 | 25478927 |
US |
72 | 1 |
Hypertension, Blood glucose increased, Injection site pain, Cataract, |
||||
DULAGLUTIDE, |
||||
77 | 25479111 |
CA |
54 | 2 |
Arthritis, Blood glucose increased, Cardiac failure congestive, Eye haemorrhage, Malnutrition, Multi-organ disorder, Pericardial effusion, Pulmonary oedema, Thyroid disorder, Chest pain, Weight decreased, Neuropathy peripheral, Abdominal pain upper, Myalgia, Diarrhoea, Headache, |
||||
FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, FLUTICASONE PROPIONATE, INSULIN LISPRO, INSULIN HUMAN, LOSARTAN, INSULIN GLARGINE, INSULIN GLARGINE, INSULIN GLARGINE, ROSUVASTATIN, ROSUVASTATIN, SALMETEROL XINAFOATE, VALSARTAN, VALSARTAN ORAL, VALSARTAN, VALSARTAN ORAL, |
||||
78 | 25479505 |
US |
78 | 2 |
Malaise, Blood glucose increased, Hypoglycaemia, Product storage error, |
||||
INSULIN GLARGINE, INSULIN GLARGINE, INSULIN GLARGINE, GLIPIZIDE, SITAGLIPTIN AND METFORMIN HYDROCHLORIDE, |
||||
79 | 25479899 |
US |
81 | 2 |
Blood glucose increased, Product dose omission issue, |
||||
INSULIN HUMAN, |
||||
80 | 25479902 |
CN |
64 | 1 |
Blood glucose increased, Decreased appetite, |
||||
DULAGLUTIDE, |
||||
81 | 25479904 |
US |
72 | 1 |
Neoplasm malignant, Blood glucose increased, Hypoacusis, Diabetes mellitus, |
||||
DULAGLUTIDE, |
||||
82 | 25479909 |
US |
5 | 2 |
Diabetic ketoacidosis, Drug ineffective, Blood glucose increased, |
||||
INSULIN LISPRO-AABC, |
||||
83 | 25479941 |
US |
1 | |
Device malfunction, Device malfunction, Device malfunction, Blood uric acid increased, Gout, Blood glucose increased, |
||||
INSULIN ASPART, INSULIN ASPART, INSULIN DEGLUDEC, |
||||
84 | 25480073 |
PL |
77 | 2 |
Hepatotoxicity, Blood glucose increased, Anaemia, Neutropenia, |
||||
ABEMACICLIB, ABEMACICLIB, ABEMACICLIB, ABEMACICLIB, LETROZOLE, LETROZOLE TABLETS, ANASTROZOLE, ANASTROZOLE TABLETS, |
||||
85 | 25480192 |
US |
52 | 2 |
Accidental underdose, Accidental underdose, Blood glucose increased, Malaise, Injection site bruising, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, |
||||
86 | 25480253 |
US |
60 | 2 |
Product dose omission issue, Blood glucose increased, |
||||
DULAGLUTIDE, DULAGLUTIDE, |
||||
87 | 25480276 |
CN |
62 | 1 |
Rash, Pruritus, Blood glucose increased, White blood cell count decreased, Haemoglobin decreased, Weight decreased, |
||||
ENFORTUMAB VEDOTIN, ENFORTUMAB VEDOTIN, |
||||
88 | 25480690 |
US |
49 | 2 |
Blood glucose increased, Product dose omission issue, |
||||
INSULIN GLARGINE, |
||||
89 | 25480880 |
US |
47 | 2 |
Headache, Blood glucose increased, Dizziness, Asthenia, |
||||
PREDNISONE, |
||||
90 | 25480900 |
US |
87 | 2 |
Blood glucose increased, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
91 | 25480925 |
US |
50 | 2 |
Abdominal pain, Drug ineffective, Drug ineffective, Gastrointestinal disorder, Vitamin D decreased, Type 2 diabetes mellitus, Anxiety, Leukocytosis, Nausea, Diarrhoea, Cough, Respiratory tract congestion, Emphysema, Hepatomegaly, Urethral disorder, Pain, Chronic graft versus host disease in skin, Schizophrenia, Drug ineffective, Blood sodium decreased, Blood glucose increased, Blood urea increased, White blood cell count increased, Blood alkaline phosphatase increased, Red cell distribution width increased, Platelet count increased, Monocyte count increased, |
||||
IBRUTINIB, PREDNISONE, PREDNISONE, BUDESONIDE, MONTELUKAST SODIUM, MONTELUKAST, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACYCLOVIR, ALBUTEROL SULFATE, CLOBETASOL PROPIONATE, CLOBETASOL PROPIONATE OINTMENT USP, 0.05%, CLONIDINE, CYCLOSPORINE, ERYTHROMYCIN, FERROUS SULFATE, FLUTICASONE PROPIONATE, GABAPENTIN, HALOPERIDOL, HALOPERIDOL LACTATE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, EMPAGLIFLOZIN, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, MAXIMUM STRENGTH PAIN RELIEVER, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, PALIPERIDONE PALMITATE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, POSACONAZOLE, POSACONAZOLE DELAYED-RELEASE, ROSUVASTATIN CALCIUM, TRAZODONE HYDROCHLORIDE, VILAZODONE HYDROCHLORIDE, CLONIDINE HYDROCHLORIDE, CLONIDINE, PETROLATUM, WHITE PETROLATUM, ISHANCARE HEMORRHOID CREAM, PIPERACILLIN SODIUM,TAZOBACTAM SODIUM, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NAPROXEN, NAPROXEN SODIUM, RUXOLITINIB, BELUMOSUDIL, RITUXIMAB, |
||||
92 | 25470800 |
US |
54 | 1 |
Blood glucose increased, Blood glucose decreased, |
||||
INSULIN LISPRO, INSULIN LISPRO, |
||||
93 | 25470806 |
US |
71 | 2 |
Blood glucose increased, |
||||
INSULIN LISPRO, TIRZEPATIDE, EMPAGLIFLOZIN, |
||||
94 | 25471689 |
US |
2 | |
Blood glucose increased, Incorrect dose administered, Injection site erythema, |
||||
DULAGLUTIDE, DULAGLUTIDE, |
||||
95 | 25471789 |
JP |
71 | 2 |
Renal impairment, Diabetes mellitus inadequate control, Hypoglycaemia, Blood glucose increased, Product use issue, |
||||
INSULIN DEGLUDEC, HUMAN INSULIN, |
||||
96 | 25471809 |
US |
2 | |
Oesophageal disorder, Anal incontinence, Diarrhoea, Anxiety, Flatulence, Blood glucose increased, Nausea, Abdominal pain upper, Off label use, |
||||
SEMAGLUTIDE, SEMAGLUTIDE, SEMAGLUTIDE, |
||||
97 | 25472242 |
CN |
59 | 2 |
Mental impairment, Myelosuppression, White blood cell count decreased, Neutrophil count decreased, Haemoglobin decreased, Platelet count decreased, Irritability, Anger, Agitation, Pallor, Lymphadenopathy, Breath sounds abnormal, Abdominal distension, Serum amyloid A protein increased, Prealbumin decreased, Blood alkaline phosphatase decreased, Protein total decreased, Blood albumin decreased, Blood cholinesterase decreased, Cystatin C increased, Blood potassium decreased, Blood sodium increased, Blood calcium decreased, Blood magnesium decreased, Blood phosphorus decreased, Interleukin level increased, Procalcitonin increased, Activated partial thromboplastin time shortened, Blood fibrinogen decreased, Thrombin time prolonged, Fibrin D dimer increased, Blood glucose increased, Abdominal pain, Pyrexia, Blood lactate dehydrogenase increased, Blood urea increased, |
||||
CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, RITUXIMAB, EPIRUBICIN HYDROCHLORIDE, POLATUZUMAB VEDOTIN, |
||||
98 | 25472404 |
US |
2 | |
Blood glucose increased, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
99 | 25472682 |
CA |
||
Autoimmune disorder, Osteoporotic fracture, Spinal fracture, Asthenia, Blood glucose fluctuation, Blood iron decreased, Blood glucose increased, Carpal tunnel syndrome, Contusion, Corneal deposits, Cough, Dizziness, Dizziness, Flushing, Flushing, Flushing, Gastrointestinal microorganism overgrowth, Insomnia, Intestinal polyp, Oropharyngeal pain, Pain, Pain, Pain in extremity, Pancreatic polypeptide level decreased, Photopsia, SARS-CoV-2 test positive, Skin mass, Weight decreased, Rash, Fatigue, Flatulence, Decreased appetite, Constipation, Abdominal distension, Abdominal pain upper, Headache, Nausea, Headache, Nausea, Pyrexia, |
||||
TELOTRISTAT ETHYL, LANREOTIDE ACETATE, LORAZEPAM, CALCIUM, HYDROMORPHONE HYDROCHLORIDE, ERGOCALCIFEROL, ALENDRONATE SODIUM, HUMAN IMMUNOGLOBULIN G, LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HCL, PREGABALIN, MAGNESIUM, METHYLPREDNISOLONE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METOCLOPRAMIDE, METOCLOPRAMIDE HYDROCHLORIDE, PREGABALIN, RITUXIMAB, OCTREOTIDE ACETATE, LEVOTHYROXINE SODIUM, DULOXETINE HYDROCHLORIDE, |
||||
100 | 25472701 |
US |
||
Hot flush, Fatigue, Arthralgia, Blood glucose increased, Libido decreased, Musculoskeletal pain, |
||||
RELUGOLIX, RELUGOLIX, ACETIC ACID, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ERGOCALCIFEROL, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, GLIPIZIDE, INSULIN GLARGINE, LISINOPRIL, MELOXICAM, NITROGLYCERIN, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, RANOLAZINE, DICLOFENAC SODIUM, |
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-07-29